The single-cell and spatial genomics company is planning a 50 percent increase in headcount, including the addition of 100 people to its commercial organization.
Net loss for Q4 and the year included a $406.9 million in-process research and development expense related to the acquisitions of ReadCoor and Cartana.
The Chinese firms have agreed to work together to develop commercial analytical and artificial intelligence-based computing platforms for single-cell genomics.
As researchers embrace single-nucleus analysis to probe previously intractable tissues, companies are trying to deliver more reliable sample preparation.
For the three months ended Sept. 30, the company reported $71.8 million in revenues, up from $61.2 million in Q3 2019 and beating the average Wall Street estimate.
Translational informatics company Paradigm4's new Reveal: SingleCell app is built on its core SciDB platform that supports fast querying of large multiomic datasets.
